Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Cancer » Breast Cancer: Causes, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
The Life and Times of Cleopatra, Queen of Egypt: A Study in the Origin of the Roman Empire
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Maspin and Cathepsin D Partnership in Regulating Mammary Gland Development and Breast Cancer, pp. 161-176
Tell A Friend
Tell someone you know about this product.
Maspin and Cathepsin D Partnership in Regulating Mammary Gland Development and Breast Cancer, pp. 161-176 $100.00
Authors:  Zhila Khalkhali-Ellis, Ming Zhang, Mary J.C. Hendrix, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois and others
Maspin (mammary serine protease inhibitor) was identified in 1994
by subtractive hybridization analysis of normal mammary tissue and
breast cancer cell lines. Although Maspin exhibited sequence homology
with members of the serine protease inhibitor superfamily, based on its
structure and in the absence of an identified protease ligand, Maspin was
considered a non-inhibitory serpin. Maspin is expressed in myoepithelial,
epithelial and adipocyte components of mammary tissue, and plays a
critical role in mammary gland development. After a decade of intensive
research, Maspin is now recognized as a multifaceted protein, interacting
with a diverse group of intra- and extra-cellular proteins, regulating a
multitude of cellular functions.
Our laboratory has identified the aspartyl lysosomal proteinase
cathepsin D (CatD) as a putative Maspin binding partner. Apart from its
well studied function in intercellular clearance of proteins, CatD is
critically involved in apoptotic cell death. In addition, excessive
production and aberrant secretion of CatD are believed to contribute to
breast cancer progression and metastasis. To date, our studies have
illuminated novel aspects of the CatD and Maspin partnership in
regulating key stages of normal mammary gland differentiation and
remodeling. In this short communication we will examine this complex
interaction, and speculate on how alteration in pathways operative in
mammary gland remodeling could promote malignant growth. 

Available Options:
This Item Is Currently Unavailable.
Special Focus Titles
01.Peter Singerís Ethics: A Critical Appraisal
02.Sexism: Past, Present and Future Perspectives
03.Body and Politics: Elite Disability Sport in China
04.Childhood and Adolescence: Tribute to Emanuel Chigier, 1928-2017
05.Renal Replacement Therapy: Controversies and Future Trends
06.Food-Drug Interactions: Pharmacokinetics, Prevention and Potential Side Effects
07.Terrorism and Violence in Islamic History and Theological Responses to the Arguments of Terrorists
08.International Event Management: Bridging the Gap between Theory and Practice
09.The Sino-Indian Border War and the Foreign Policies of China and India (1950-1965)
10.Tsunamis: Detection, Risk Assessment and Crisis Management
11.Sediment Watch: Monitoring, Ecological Risk Assessment and Environmental Management
12.Self-Regulated Learners: Strategies, Performance, and Individual Differences

Nova Science Publishers
© Copyright 2004 - 2018

Maspin and Cathepsin D Partnership in Regulating Mammary Gland Development and Breast Cancer, pp. 161-176